免疫检查点抑制剂在头部和部状细胞癌中的使用:当前的情况和未来的前景

Elinor R Gatfield1, John Tadross2,3,4, William Ince1

  • 1Oncology Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.

概括

免疫检查点抑制剂对头部和部状细胞癌有前途. 本综述审查了它们在所有疾病阶段的使用,包括治愈和转移的设置.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K